# CaliberCos Inc.: financial statements, quarterly

CWD · Nasdaq · CIK 1627282 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cwd.md) · [Financials](/companies/cwd/financials.md) · [Filings](/companies/cwd/filings.md) · [Insiders](/companies/cwd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cwd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [17.0](/filings/0001627282-24-000124.md) | [(46.4) d](/filings/0001627282-25-000028.md) | [4.7](/filings/0001627282-25-000059.md) | [4.2](/filings/0001627282-25-000100.md) | [7.4](/filings/0001627282-25-000157.md) | [4.5 d](/filings/0001627282-26-000015.md) | [3.5](/filings/0001627282-26-000034.md) | [4.1](/filings/0001627282-26-000058.md) | [3.5](/filings/0001627282-25-000157.md) | [4.0 d](/filings/0001627282-26-000015.md) | [4.1](/filings/0001627282-26-000034.md) | [3.7](/filings/0001627282-26-000058.md) |
| Interest expense | $m | [1.3](/filings/0001627282-23-000059.md) | [1.3 d](/filings/0001627282-24-000039.md) | [1.3](/filings/0001627282-24-000058.md) | [1.3](/filings/0001627282-25-000100.md) | [1.3](/filings/0001627282-25-000157.md) | [1.5 d](/filings/0001627282-26-000015.md) | [1.6](/filings/0001627282-26-000034.md) | [1.7](/filings/0001627282-26-000058.md) | [1.9](/filings/0001627282-25-000157.md) | [1.5 d](/filings/0001627282-26-000015.md) | [1.4](/filings/0001627282-26-000034.md) | [1.3](/filings/0001627282-26-000058.md) |
| Income tax | $m | [0.0](/filings/0001627282-24-000124.md) | [0.0 d](/filings/0001627282-25-000028.md) | [0.0](/filings/0001627282-25-000059.md) | [0.0](/filings/0001627282-25-000100.md) | [0.0](/filings/0001627282-25-000157.md) | [0.0 d](/filings/0001627282-26-000015.md) | [0.0](/filings/0001627282-26-000034.md) | [0.0](/filings/0001627282-26-000058.md) | [0.0](/filings/0001627282-25-000157.md) | [0.0 d](/filings/0001627282-26-000015.md) | [0.0](/filings/0001627282-26-000034.md) | [0.0](/filings/0001627282-26-000058.md) |
| Net income | $m | [(3.4)](/filings/0001627282-24-000124.md) | [(2.4) d](/filings/0001627282-25-000028.md) | [(3.8)](/filings/0001627282-25-000059.md) | [(4.7)](/filings/0001627282-25-000100.md) | [0.1](/filings/0001627282-25-000157.md) | [(11.4) d](/filings/0001627282-26-000015.md) | [(4.4)](/filings/0001627282-26-000034.md) | [(5.3)](/filings/0001627282-26-000058.md) | [(4.4)](/filings/0001627282-25-000157.md) | [(7.7) d](/filings/0001627282-26-000015.md) | [(3.6)](/filings/0001627282-26-000034.md) | [(3.4)](/filings/0001627282-26-000058.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0001627282-24-000124.md) | not reported | [(3.53)](/filings/0001627282-25-000059.md) | [(4.34)](/filings/0001627282-25-000100.md) | [0.12](/filings/0001627282-25-000157.md) | not reported | [(3.85)](/filings/0001627282-26-000034.md) | [(4.15)](/filings/0001627282-26-000058.md) | [(1.65)](/filings/0001627282-25-000157.md) | not reported | [(0.52)](/filings/0001627282-26-000034.md) | [(0.38)](/filings/0001627282-26-000058.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0001627282-24-000124.md) | not reported | [(3.53)](/filings/0001627282-25-000059.md) | [(4.34)](/filings/0001627282-25-000100.md) | [0.15](/filings/0001627282-25-000157.md) | not reported | [(3.85)](/filings/0001627282-26-000034.md) | [(4.15)](/filings/0001627282-26-000058.md) | [(1.65)](/filings/0001627282-25-000157.md) | not reported | [(0.52)](/filings/0001627282-26-000034.md) | [(0.38)](/filings/0001627282-26-000058.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.5](/filings/0001627282-24-000124.md) | [3.8](/filings/0001627282-26-000015.md) | [2.1](/filings/0001627282-25-000059.md) | [1.8](/filings/0001627282-25-000100.md) | [1.6](/filings/0001627282-25-000157.md) | [2.3](/filings/0001627282-26-000058.md) | [1.6](/filings/0001627282-26-000034.md) | [0.7](/filings/0001627282-26-000058.md) | [10.9](/filings/0001627282-25-000157.md) | [2.9](/filings/0001627282-26-000058.md) | [0.9](/filings/0001627282-26-000034.md) | [1.8](/filings/0001627282-26-000058.md) |
| Total assets | $m | [325](/filings/0001627282-23-000059.md) | [299](/filings/0001627282-25-000028.md) | [201](/filings/0001627282-24-000058.md) | [195](/filings/0001627282-24-000101.md) | [159](/filings/0001627282-24-000124.md) | [106](/filings/0001627282-26-000015.md) | [104](/filings/0001627282-25-000059.md) | [59.3](/filings/0001627282-25-000100.md) | [82.6](/filings/0001627282-25-000157.md) | [135](/filings/0001627282-26-000058.md) | [180](/filings/0001627282-26-000034.md) | [178](/filings/0001627282-26-000058.md) |
| Total liabilities | $m | [250](/filings/0001627282-23-000059.md) | [233](/filings/0001627282-25-000028.md) | [115](/filings/0001627282-24-000058.md) | [100](/filings/0001627282-24-000101.md) | [95.3](/filings/0001627282-24-000124.md) | [94.3](/filings/0001627282-26-000015.md) | [96.3](/filings/0001627282-25-000059.md) | [76.9](/filings/0001627282-25-000100.md) | [76.5](/filings/0001627282-25-000157.md) | [109](/filings/0001627282-26-000058.md) | [141](/filings/0001627282-26-000034.md) | [143](/filings/0001627282-26-000058.md) |
| Shareholders' equity | $m | [4.3](/filings/0001627282-23-000059.md) | [2.6](/filings/0001627282-25-000028.md) | [(0.7)](/filings/0001627282-24-000058.md) | [(4.7)](/filings/0001627282-24-000101.md) | [(3.8)](/filings/0001627282-24-000124.md) | [(12.6)](/filings/0001627282-26-000015.md) | [(15.8)](/filings/0001627282-25-000059.md) | [(19.9)](/filings/0001627282-25-000100.md) | [4.2](/filings/0001627282-25-000157.md) | [1.3](/filings/0001627282-26-000058.md) | [1.3](/filings/0001627282-26-000034.md) | [(1.4)](/filings/0001627282-26-000058.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(7,683) d](/filings/0001627282-24-000124.md) | [(7,578) d](/filings/0001627282-25-000028.md) | [(1,527)](/filings/0001627282-25-000059.md) | [1,402 d](/filings/0001627282-25-000100.md) | [(74.0) d](/filings/0001627282-25-000157.md) | [754 d](/filings/0001627282-26-000015.md) | [(1,738)](/filings/0001627282-26-000034.md) | [(1,170) d](/filings/0001627282-26-000058.md) | [(4,615) d](/filings/0001627282-25-000157.md) | [(4,542) d](/filings/0001627282-26-000015.md) | [(2,635)](/filings/0001627282-26-000034.md) | [(2,655) d](/filings/0001627282-26-000058.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.1](/filings/0001627282-23-000059.md) | [18.2](/filings/0001627282-24-000058.md) | [19.6](/filings/0001627282-24-000101.md) | [21.2](/filings/0001627282-24-000124.md) | [1.1](/filings/0001627282-25-000059.md) | [1.1](/filings/0001627282-25-000100.md) | [1.4](/filings/0001627282-25-000157.md) | [1.1](/filings/0001627282-26-000034.md) | [1.3](/filings/0001627282-26-000058.md) | [2.6](/filings/0001627282-25-000157.md) | [7.0](/filings/0001627282-26-000034.md) | [8.8](/filings/0001627282-26-000058.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,384,653 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001627282-26-000058.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.